-
K.
Lucas,
L.
Bao,
Richard
Bruggeman,
Kimberly
Dunham,
C.
Specht
(2011)
The detection of CMV pp65 and IE1 in glioblastoma multiforme
Journal of Neuro-Oncology, 103
-
Yoshiteru
Nakano,
E.
Kuroda,
Tomohiro
Kito,
S.
Uematsu,
S.
Akira,
A.
Yokota,
S.
Nishizawa,
U.
Yamashita
(2008)
Induction of prostaglandin E2 synthesis and microsomal prostaglandin E synthase-1 expression in murine microglia by glioma-derived soluble factors. Laboratory investigation.
Journal of neurosurgery, 108 2
-
F.
Colombo,
L.
Barzon,
E.
Franchin,
M.
Pacenti,
V.
Pinna,
D.
Danieli,
M.
Zanusso,
G.
Palù
(2005)
Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results
Cancer Gene Therapy, 12
-
N.
Yajima,
R.
Yamanaka,
T.
Mine,
N.
Tsuchiya,
Jumpei
Homma,
Masakazu
Sano,
T.
Kuramoto,
Yayoi
Obata,
N.
Komatsu,
Y.
Arima,
A.
Yamada,
M.
Shigemori,
K.
Itoh,
R.
Tanaka
(2005)
Immunologic Evaluation of Personalized Peptide Vaccination for Patients with Advanced Malignant Glioma
Clinical Cancer Research, 11
-
A.
Myint,
M.
Schwarz,
H.
Steinbusch,
B.
Leonard
(2009)
Neuropsychiatric disorders related to interferon and interleukins treatment
Metabolic Brain Disease, 24
-
A.
Alomari,
J.
Cohen,
A.
Vortmeyer,
A.
Chiang,
S.
Gettinger,
S.
Goldberg,
H.
Kluger,
V.
Chiang
(2016)
Possible Interaction of Anti–PD-1 Therapy with the Effects of Radiosurgery on Brain Metastases
Cancer Immunology Research, 4
-
P.
Harter,
S.
Bernatz,
Alexander
Scholz,
P.
Zeiner,
Jenny
Zinke,
M.
Kiyose,
S.
Blasel,
R.
Beschorner,
C.
Senft,
B.
Bender,
M.
Ronellenfitsch,
H.
Wikman,
M.
Glatzel,
M.
Meinhardt,
T.
Juratli,
J.
Steinbach,
K.
Plate,
J.
Wischhusen,
B.
Weide,
M.
Mittelbronn
(2015)
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Oncotarget, 6
-
R.
Brentjens,
Raymond
Yeh,
Y.
Bernal,
I.
Rivière,
M.
Sadelain
(2010)
Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial.
Molecular therapy : the journal of the American Society of Gene Therapy, 18 4
-
M.
Mitchell
(1989)
Relapse in the central nervous system in melanoma patients successfully treated with biomodulators.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 7 11
-
W.
Dummer,
A.
Niethammer,
R.
Baccala,
B.
Lawson,
N.
Wagner,
R.
Reisfeld,
A.
Theofilopoulos
(2002)
T cell homeostatic proliferation elicits effective antitumor autoimmunity.
The Journal of clinical investigation, 110 2
-
S.
Phuphanich,
C.
Wheeler,
J.
Rudnick,
M.
Mazer,
Hongqiang
Wang,
M.
Nuno,
J.
Richardson,
Xuemo
Fan,
J.
Ji,
R.
Chu,
J.
Bender,
E.
Hawkins,
C.
Patil,
K.
Black,
John
Yu
(2012)
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
Cancer Immunology, Immunotherapy, 62
-
H.
Fathallah-Shaykh,
C.
Zimmerman,
H.
Morgan,
E.
Rushing,
S.
Schold,
D.
Unwin
(1996)
Response of primary leptomeningeal melanoma to intrathecal recombinant interleukin-2. A case report.
Cancer, 77 8
-
D.
Reardon,
P.
Gokhale,
Sarah
Klein,
K.
Ligon,
S.
Rodig,
S.
Ramkissoon,
Kristen
Jones,
A.
Conway,
X.
Liao,
Jun
Zhou,
P.
Wen,
A.
Abbeele,
A.
Abbeele,
F.
Hodi,
L.
Qin,
N.
Kohl,
A.
Sharpe,
G.
Dranoff,
G.
Freeman
(2015)
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
Cancer Immunology Research, 4
-
E.
Bouffet,
Valérie
Larouche,
B.
Campbell,
D.
Merico,
Richard
Borja,
M.
Aronson,
C.
Durno,
J.
Krueger,
V.
Cabric,
V.
Ramaswamy,
N.
Zhukova,
G.
Mason,
R.
Farah,
S.
Afzal,
M.
Yalon,
G.
Rechavi,
Vanan
Magimairajan,
M.
Walsh,
S.
Constantini,
R.
Dvir,
R.
Elhasid,
A.
Reddy,
M.
Osborn,
M.
Sullivan,
J.
Hansford,
A.
Dodgshun,
N.
Klauber-DeMore,
L.
Peterson,
Sunil
Patel,
S.
Lindhorst,
J.
Atkinson,
Z.
Cohen,
R.
Laframboise,
P.
Dirks,
Michael
Taylor,
D.
Malkin,
S.
Albrecht,
Roy
Dudley,
N.
Jabado,
C.
Hawkins,
A.
Shlien,
U.
Tabori
(2016)
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 19
-
Jennifer
Brudno,
J.
Kochenderfer
(2016)
Toxicities of chimeric antigen receptor T cells: recognition and management.
Blood, 127 26
-
C.
Robert,
L.
Thomas,
I.
Bondarenko,
S.
O'Day,
J.
Weber,
C.
Garbe,
C.
Lebbé,
J.
Baurain,
A.
Testori,
J.
Grob,
N.
Davidson,
J.
Richards,
M.
Maio,
A.
Hauschild,
W.
Miller,
P.
Gascón,
M.
Lotem,
K.
Harmankaya,
R.
Ibrahim,
S.
Francis,
Tai-Tsang
Chen,
R.
Humphrey,
A.
Hoos,
J.
Wolchok
(2011)
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.
The New England journal of medicine, 364 26
-
R.
Prehn,
J.
Main
(1957)
Immunity to methylcholanthrene-induced sarcomas.
Journal of the National Cancer Institute, 18 6
-
Yonghao
Cao,
A.
Nylander,
S.
Ramanan,
B.
Goods,
G.
Ponath,
R.
Zabad,
V.
Chiang,
A.
Vortmeyer,
D.
Hafler,
D.
Pitt
(2016)
CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment
Neurology, 86
-
A.
Schuessler,
Corey
Smith,
L.
Beagley,
G.
Boyle,
S.
Rehan,
Katherine
Matthews,
L.
Jones,
T.
Crough,
Vijayendra
Dasari,
K.
Klein,
Amy
Smalley,
Hamish
Alexander,
D.
Walker,
R.
Khanna
(2014)
Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma.
Cancer research, 74 13
-
C.
Söderberg-Nauclér,
A.
Rahbar,
G.
Stragliotto
(2013)
Survival in patients with glioblastoma receiving valganciclovir.
The New England journal of medicine, 369 10
-
K.
Lillehei,
D.
Mitchell,
Stephen
Johnson,
Larry
McCleary,
Carol
Kruse
(1991)
Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy.
Neurosurgery, 28 1
-
C.
Pelloski,
K.
Ballman,
A.
Furth,
Li
Zhang,
E.
Lin,
E.
Sulman,
K.
Bhat,
J.
Mcdonald,
W.
Yung,
H.
Colman,
S.
Woo,
A.
Heimberger,
D.
Suki,
M.
Prados,
Susan
Chang,
Fredrick
Barker,
J.
Buckner,
C.
James,
K.
Aldape
(2007)
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 16
-
S.
Batra,
Shobha
Castelino‐Prabhu,
C.
Wikstrand,
Xiaopei
Zhu,
P.
Humphrey,
H.
Friedman,
D.
Bigner
(1995)
Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 6 10
-
C.
Vecht,
C.
Keohane,
R.
Menon,
C.
Punt,
G.
Stoter
(1990)
Acute fatal leukoencephalopathy after interleukin-2 therapy.
The New England journal of medicine, 323 16
-
G.
Manelis,
S.
Shasha,
J.
Manelis,
H.
Suprun,
E.
Robinson
(1978)
Spontaneous regression of malignant melanoma.
Oncology, 35 2
-
T.
Jessy
(2011)
Immunity over inability: The spontaneous regression of cancer
Journal of Natural Science, Biology, and Medicine, 2
-
L.
Liau,
R.
Prins,
S.
Kiertscher,
S.
Odesa,
T.
Kremen,
A.
Giovannone,
J.
Lin,
D.
Chute,
P.
Mischel,
T.
Cloughesy,
M.
Roth
(2005)
Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment
Clinical Cancer Research, 11
-
H.
Suit,
V.
Silobrčić
(1967)
Tumor-specific antigen(s) in a spontaneous mammary carcinoma of C3H mice. II. Active immunization of mammary-tumor-agent-free mice.
Journal of the National Cancer Institute, 39 6
-
H.
Torikai,
L.
Cooper
(2016)
Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors.
Molecular therapy : the journal of the American Society of Gene Therapy, 24 7
-
G.
Plautz,
G.
Barnett,
David
Miller,
B.
Cohen,
R.
Prayson,
J.
Krauss,
M.
Luciano,
D.
Kangisser,
S.
Shu
(1998)
Systemic T cell adoptive immunotherapy of malignant gliomas.
Journal of neurosurgery, 89 1
-
G.
Stragliotto,
A.
Rahbar,
Nina
Solberg,
A.
Lilja,
C.
Taher,
A.
Orrego,
B.
Bjurman,
C.
Tammik,
P.
Skarman,
I.
Peredo,
C.
Söderberg-Nauclér
(2013)
Effects of valganciclovir as an add‐on therapy in patients with cytomegalovirus‐positive glioblastoma: A randomized, double‐blind, hypothesis‐generating study
International Journal of Cancer, 133
-
M.
Dudley,
J.
Wunderlich,
J.
Yang,
R.
Sherry,
S.
Topalian,
N.
Restifo,
R.
Royal,
U.
Kammula,
D.
White,
S.
Mavroukakis,
L.
Rogers,
Gerald
Gracia,
S.
Jones,
David
Mangiameli,
M.
Pelletier,
J.
Gea-Banacloche,
M.
Robinson,
D.
Berman,
A.
Filie,
A.
Abati,
S.
Rosenberg
(2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 10
-
C.
Wood,
P.
Srivastava,
R.
Bukowski,
L.
Lacombe,
A.
Gorelov,
Sergei
Gorelov,
P.
Mulders,
H.
Zieliński,
A.
Hoos,
F.
Teofilovici,
L.
Isakov,
R.
Flanigan,
R.
Figlin,
Renu
Gupta,
B.
Escudier
(2008)
An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial
The Lancet, 372
-
Stephanie
Downey,
J.
Klapper,
F.
Smith,
J.
Yang,
R.
Sherry,
R.
Royal,
U.
Kammula,
M.
Hughes,
T.
Allen,
Catherine
Levy,
M.
Yellin,
G.
Nichol,
D.
White,
S.
Steinberg,
S.
Rosenberg
(2007)
Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade
Clinical Cancer Research, 13
-
E.
Olapade-Olaopa,
D.
Moscatello,
E.
Mackay,
T.
Horsburgh,
D.
Sandhu,
T.
Terry,
AJ
Wong,
FK
Habib
(1999)
Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer
British Journal of Cancer, 82
-
Y.
Okamoto,
K.
Shimizu,
K.
Tamura,
Y.
Miyao,
M.
Yamada,
Y.
Matsui,
N.
Tsuda,
H.
Takimoto,
T.
Hayakawa,
H.
Mogami
(2005)
An adoptive immunotherapy of patients with medulloblastoma by lymphokine-activated killer cells (LAK)
Acta Neurochirurgica, 94
-
W.
Asavaroengchai,
Y.
Kotera,
J.
Mulé
(2002)
Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery
Proceedings of the National Academy of Sciences of the United States of America, 99
-
M.
Chu,
M.
Fesler,
E.
Armbrecht,
S.
Fosko,
E.
Hsueh,
J.
Richart
(2013)
High-Dose Interleukin-2 (HD IL-2) Therapy Should Be Considered for Treatment of Patients with Melanoma Brain Metastases
Chemotherapy Research and Practice, 2013
-
Peter
Attia,
G.
Phan,
A.
Maker,
M.
Robinson,
M.
Quezado,
J.
Yang,
R.
Sherry,
S.
Topalian,
U.
Kammula,
R.
Royal,
N.
Restifo,
Leah
Haworth,
Catherine
Levy,
S.
Mavroukakis,
G.
Nichol,
M.
Yellin,
S.
Rosenberg
(2005)
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 25
-
F.
Burnet
(1970)
The concept of immunological surveillance.
Progress in experimental tumor research, 13
-
A.
Heimberger,
L.
Crotty,
G.
Archer,
R.
McLendon,
A.
Friedman,
G.
Dranoff,
D.
Bigner,
J.
Sampson
(2000)
Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma
Journal of Neuroimmunology, 103
-
S.
Jacobs,
D.
Wilson,
P.
Kornblith,
E.
Grimm
(1986)
Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial.
Cancer research, 46 4 Pt 2
-
K.
Margolin,
M.
Ernstoff,
O.
Hamid,
D.
Lawrence,
D.
McDermott,
I.
Puzanov,
J.
Wolchok,
Joseph
Clark,
M.
Sznol,
T.
Logan,
J.
Richards,
T.
Michener,
Á.
Balogh,
K.
Heller,
F.
Hodi
(2012)
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.
The Lancet. Oncology, 13 5
-
J.
Villadolid,
A.
Amin
(2015)
Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities.
Translational lung cancer research, 4 5
-
J.
Weber,
A.
Amin,
D.
Minor,
J.
Siegel,
D.
Berman,
S.
O'Day
(2011)
Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial
Melanoma Research, 21
-
K.
Chow,
Swati
Naik,
Sunitha
Kakarla,
V.
Brawley,
D.
Shaffer,
Zhongzhen
Yi,
N.
Rainusso,
Meng-fen
Wu,
Hao
Liu,
Y.
Kew,
R.
Grossman,
S.
Powell,
Dean
Lee,
N.
Ahmed,
S.
Gottschalk
(2013)
T cells redirected to EphA2 for the immunotherapy of glioblastoma.
Molecular therapy : the journal of the American Society of Gene Therapy, 21 3
-
J.
Zou,
L.
Morford,
C.
Chougnet,
A.
Dix,
A.
Brooks,
N.
Torres,
J.
Shuman,
J.
Coligan,
W.
Brooks,
T.
Roszman,
G.
Shearer
(1999)
Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers.
Journal of immunology, 162 8
-
N.
Ahmed,
V.
Salsman,
Y.
Kew,
D.
Shaffer,
S.
Powell,
Y.
Zhang,
R.
Grossman,
H.
Heslop,
S.
Gottschalk
(2010)
HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
Clinical Cancer Research, 16
-
P.
Ehrlich,
C.
Bolduan,
Howard
(2009)
Collected studies on immunity
-
J.
Schuster,
R.
Lai,
L.
Recht,
D.
Reardon,
N.
Paleologos,
M.
Groves,
M.
Mrugala,
R.
Jensen,
J.
Baehring,
A.
Sloan,
G.
Archer,
D.
Bigner,
S.
Cruickshank,
Jennifer
Green,
T.
Keler,
T.
Davis,
A.
Heimberger,
J.
Sampson
(2015)
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.
Neuro-oncology, 17 6
-
F.
Torino,
A.
Barnabei,
R.
Paragliola,
P.
Marchetti,
R.
Salvatori,
S.
Corsello
(2013)
Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses.
European journal of endocrinology, 169 6
-
A.
Giacomo,
P.
Ascierto,
P.
Queirolo,
L.
Pilla,
R.
Ridolfi,
M.
Santinami,
A.
Testori,
E.
Simeone,
M.
Guidoboni,
A.
Maurichi,
L.
Orgiano,
G.
Spadola,
M.
Vecchio,
R.
Danielli,
L.
Calabrò,
Diego
Annesi,
Diana
Giannarelli,
C.
Maccalli,
E.
Fonsatti,
Giorgio
Parmiani,
Michele
Maio
(2015)
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology, 26 4
-
M.
Mathew,
M.
Tam,
P.
Ott,
A.
Pavlick,
S.
Rush,
B.
Donahue,
J.
Golfinos,
E.
Parker,
P.
Huang,
A.
Narayana
(2013)
Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery
Melanoma Research, 23
-
C.
Huettner,
S.
Czub,
S.
Kerkau,
W.
Roggendorf,
J.
Tonn
(1997)
Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro.
Anticancer research, 17 5A
-
P.
Siesjö,
E.
Visse,
Hans-Olov
Sjögren
(1996)
Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-gamma treatment.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy, 19 5
-
R.
Merchant,
D.
McVicar,
L.
Merchant,
Harold
Young
(2004)
Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-α. Results of a phase I clinical trial
Journal of Neuro-Oncology, 12
-
J.
Bradstreet,
M.
Ruggiero,
S.
Pacini
(2015)
Commentary: Structural and functional features of central nervous system lymphatic vessels
Frontiers in Neuroscience, 9
-
R.
Dillman,
C.
Duma,
P.
Schiltz,
C.
Depriest,
R.
Ellis,
K.
Okamoto,
L.
Beutel,
C.
Leon,
S.
Chico
(2004)
Intracavitary Placement of Autologous Lymphokine-Activated Killer (LAK) Cells after Resection of Recurrent Glioblastoma
Journal of Immunotherapy, 27
-
M.
Konstantinou,
C.
Dutriaux,
C.
Gaudy-Marqueste,
L.
Mortier,
C.
Bédane,
C.
Girard,
S.
Thellier,
T.
Jouary,
J.
Grob,
M.
Richard,
C.
Templier,
Lilia
Sakji,
B.
Guillot,
C.
Paul,
N.
Meyer
(2014)
Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients.
Acta dermato-venereologica, 94 1
-
B.
Karp,
J.
Yang,
M.
Khorsand,
R.
Wood,
T.
Merigan
(1996)
Multiple cerebral lesions complicating therapy with interleukin-2
Neurology, 47
-
H.
Bloom,
M.
Peckham,
A.
Richardson,
P.
Alexander,
P.
Payne,
Atkinson
Hospital,
St
Hospital,
S.
London
(1973)
Glioblastoma Multiforme: A Controlled Trial to Assess the Value of Specific Active Immunotherapy in Patients Treated by Radical Surgery and Radiotherapy
British Journal of Cancer, 27
-
V.
Koelzer,
S.
Rothschild,
D.
Zihler,
A.
Wicki,
B.
Willi,
N.
Willi,
M.
Voegeli,
G.
Cathomas,
A.
Zippelius,
K.
Mertz
(2016)
Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study
Journal for Immunotherapy of Cancer, 4
-
B.
Hemmer,
M.
Kerschensteiner,
T.
Korn
(2015)
Role of the innate and adaptive immune responses in the course of multiple sclerosis
The Lancet Neurology, 14
-
G.
Finocchiaro,
S.
Pellegatta
(2014)
Perspectives for immunotherapy in glioblastoma treatment
Current Opinion in Oncology, 26
-
D.
Reardon,
Tae-Min
Kim,
J.
Frenel,
A.
Santoro,
Juanita
Lopez,
Deepa
Subramaniam,
L.
Siu,
J.
Rodón,
K.
Tamura,
S.
Saraf,
A.
Morosky,
K.
Stein,
J.
Soria
(2016)
ATIM-35. RESULTS OF THE PHASE IB KEYNOTE-028 MULTI-COHORT TRIAL OF PEMBROLIZUMAB MONOTHERAPY IN PATIENTS WITH RECURRENT PD-L1-POSITIVE GLIOBLASTOMA MULTIFORME (GBM)
Neuro-oncology, 18
-
E.
Purev,
Dewei
Cai,
E.
Miller,
R.
Swoboda,
T.
Mayer,
Andres
Klein-Szanto,
F.
Marincola,
R.
Mick,
L.
Otvos,
W.
Wunner,
B.
Birebent,
R.
Somasundaram,
C.
Wikstrand,
D.
Bigner,
A.
DeMichele,
G.
Acs,
J.
Berlin,
D.
Herlyn
(2004)
Immune Responses of Breast Cancer Patients to Mutated Epidermal Growth Factor Receptor (EGF-RvIII, ΔEGF-R, and de2–7 EGF-R)1
The Journal of Immunology, 173
-
J.
Weber,
G.
Gibney,
R.
Sullivan,
J.
Sosman,
C.
Slingluff,
D.
Lawrence,
T.
Logan,
L.
Schuchter,
S.
Nair,
L.
Fecher,
L.
Fecher,
E.
Buchbinder,
E.
Berghorn,
Mary
Ruisi,
G.
Kong,
Joel
Jiang,
C.
Horak,
F.
Hodi
(2016)
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial.
The Lancet. Oncology, 17 7
-
N.
Lüttmann,
V.
Graetz,
O.
Haase,
T.
Eckey,
E.
Langan,
D.
Zillikens,
P.
Terheyden
(2016)
Rapid remission of symptomatic brain metastases in melanoma by programmed-death-receptor-1 inhibition.
Melanoma research, 26 5
-
A.
Dix,
W.
Brooks,
T.
Roszman,
L.
Morford
(1999)
Immune defects observed in patients with primary malignant brain tumors
Journal of Neuroimmunology, 100
-
T.
Doucette,
G.
Rao,
A.
Rao,
Li
Shen,
K.
Aldape,
Jun
Wei,
K.
Dziurzynski,
M.
Gilbert,
A.
Heimberger
(2013)
Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas
Cancer Immunology Research, 1
-
Y.
Akasaki,
Gentao
Liu,
N.
Chung,
Moneeb
Ehtesham,
K.
Black,
John
Yu
(2004)
Induction of a CD4+ T Regulatory Type 1 Response by Cyclooxygenase-2-Overexpressing Glioma1
The Journal of Immunology, 173
-
R.
Moser,
J.
Bruner,
E.
Grimm
(1991)
Biologic therapy for brain tumors
Cancer Bulletin, 43
-
John
Yu,
Gentao
Liu,
H.
Ying,
W.
Yong,
K.
Black,
C.
Wheeler
(2004)
Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma
Cancer Research, 64
-
J.
Sampson,
G.
Archer,
D.
Mitchell,
A.
Heimberger,
J.
Herndon,
Denise
Lally-Goss,
Sharon
McGehee-Norman,
Alison
Paolino,
D.
Reardon,
A.
Friedman,
H.
Friedman,
D.
Bigner
(2009)
An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
Molecular Cancer Therapeutics, 8
-
W.
Yokoyama,
M.
Altfeld,
K.
Hsu
(2010)
Natural killer cells: tolerance to self and innate immunity to viral infection and malignancy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 16 1 Suppl
-
Florence
Deauvieau,
Vincent
Ollion,
A.
Doffin,
C.
Achard,
J.
Fonteneau,
E.
Verronèse,
I.
Durand,
R.
Ghittoni,
J.
Marvel,
C.
Dezutter‐Dambuyant,
T.
Walzer,
H.
Vié,
I.
Perrot,
N.
Goutagny,
C.
Caux,
J.
Valladeau-Guilemond
(2015)
Human natural killer cells promote cross‐presentation of tumor cell‐derived antigens by dendritic cells
International Journal of Cancer, 136
-
D.
Moscatello,
M.
Holgado-Madruga,
A.
Godwin,
Gloria
Ramirez,
G.
Gunn,
P.
Zoltick,
J.
Biegel,
R.
Hayes,
A.
Wong
(1995)
Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors.
Cancer research, 55 23
-
D.
Reardon,
A.
Desjardins,
J.
Schuster,
D.
Tran,
K.
Fink,
L.
Nabors,
Gordon
Li,
D.
Bota,
R.
Lukas,
L.
Ashby,
J.
Duic,
M.
Mrugala,
A.
Werner,
L.
Vitale,
Yi
He,
Jennifer
Green,
M.
Yellin,
C.
Turner,
T.
Davis,
J.
Sampson
(2015)
IMCT-08ReACT: LONG-TERM SURVIVAL FROM A RANDOMIZED PHASE II STUDY OF RINDOPEPIMUT (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA
Neuro-oncology, 17
-
S.
Phuphanich,
C.
Wheeler,
J.
Rudnick,
M.
Mazer,
M.
Nuno,
X.
Fan,
J.
Bender,
E.
Hawkins,
K.
Black,
J.
Yu
(2011)
Glioma-associated antigens associated with prolonged survival in a phase I study of ICT-107 for patients with newly diagnosed glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 15_suppl
-
K.
Shimizu,
K.
Tamura,
M.
Yamada,
Y.
Okamoto,
Y.
Miyao,
K.
Park,
Y.
Matsui,
T.
Hayakawa,
H.
Takimoto,
H.
Mogami
(1989)
[Adoptive immunotherapy in patients with medulloblastoma by LAK cells].
No to shinkei = Brain and nerve, 41 10
-
S.
Sankhla,
J.
Nadkarni,
S.
Bhagwati
(1996)
Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors
Journal of Neuro-Oncology, 27
-
(2015)
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
-
K.
Ahmed,
D.
Stallworth,
Y.
Kim,
P.A.S.
Johnstone,
L.
Harrison,
J.
Caudell,
H.
Yu,
A.
Etame,
J.
Weber,
G.
Gibney,
G.
Gibney
(2016)
Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy.
Annals of oncology : official journal of the European Society for Medical Oncology, 27 3
-
J.
Zeng,
A.
See,
J.
Phallen,
Christopher
Jackson,
Z.
Belcaid,
J.
Ruzevick,
N.
Durham,
C.
Meyer,
T.
Harris,
E.
Albesiano,
G.
Pradilla,
E.
Ford,
J.
Wong,
H.
Hammers,
Dimitris
Mathios,
B.
Tyler,
H.
Brem,
P.
Tran,
D.
Pardoll,
C.
Drake,
M.
Lim
(2013)
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas.
International journal of radiation oncology, biology, physics, 86 2
-
R.
Stupp,
Warren
Mason,
M.
Bent,
M.
Weller,
B.
Fisher,
M.
Taphoorn,
K.
Bélanger,
A.
Brandes,
C.
Marosi,
U.
Bogdahn,
J.
Curschmann,
Robert
Janzer,
Samuel
Ludwin,
T.
Gorlia,
A.
Allgeier,
D.
Lacombe,
J.
Cairncross,
E.
Eisenhauer,
R.
Mirimanoff
(2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
The New England journal of medicine, 352 10
-
Immunocellular therapeutics phase II study demonstrates that glioblastoma patients live longer without disease progression when treated with ICT-107: study achieves progression-free survival endpoint with statistical significance; primary endpoint of overall survival not statistically significant
-
M.
Nagane,
F.
Coufal,
Hong
Lin,
O.
Bogler,
W.
Cavenee,
H.
Huang,
H.
Huang
(1996)
A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.
Cancer research, 56 21
-
J.
Graham,
R.
Graham
(1955)
Antibodies elicited by cancer in patients
Cancer, 8
-
Douglas
Johnson,
Erika
Wallender,
D.
Cohen,
Sunaina
Likhari,
J.
Zwerner,
J.
Powers,
Lisa
Shinn,
M.
Kelley,
R.
Joseph,
J.
Sosman
(2013)
Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy
Cancer Immunology Research, 1
-
R.
Prins,
H.
Soto,
Vera
Konkankit,
S.
Odesa,
Ascia
Eskin,
W.
Yong,
S.
Nelson,
L.
Liau
(2010)
Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
Clinical Cancer Research, 17
-
S.
Saris,
S.
Rosenberg,
R.
Friedman,
J.
Rubin,
D.
Barba,
E.
Oldfield
(1988)
Penetration of recombinant interleukin-2 across the blood-cerebrospinal fluid barrier.
Journal of neurosurgery, 69 1
-
S.
Goldberg,
S.
Gettinger,
A.
Mahajan,
A.
Chiang,
R.
Herbst,
M.
Sznol,
A.
Tsiouris,
J.
Cohen,
A.
Vortmeyer,
Lucia
Jilaveanu,
James
Yu,
U.
Hegde,
Stephanie
Speaker,
Matthew
Madura,
A.
Ralabate,
A.
Rivera,
E.
Rowen,
H.
Gerrish,
Xiaopan
Yao,
V.
Chiang,
H.
Kluger
(2016)
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.
The Lancet. Oncology, 17 7
-
L.
Liau,
K.
Black,
R.
Prins,
S.
Sykes,
P.
Dipatre,
T.
Cloughesy,
Donald
Becker,
J.
Bronstein
(1999)
Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.
Journal of neurosurgery, 90 6
-
P.
Jones,
D.
Cahill,
P.
Brastianos,
K.
Flaherty,
W.
Curry
(2015)
Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case series.
Neurosurgical focus, 38 3
-
M.
Mahaley,
D.
Bigner,
Lynn
Dudka,
Peggy
Wilds,
Darlene
Williams,
Thomas
Bouldin,
John
Whitaker,
Jane
Bynum
(1983)
Immunobiology of primary intracranial tumors. Part 7: Active immunization of patients with anaplastic human glioma cells: a pilot study.
Journal of neurosurgery, 59 2
-
Data safety and monitoring board recommends celldex?s phase 3 study of RINTEGA� (rindopepimut) in newly diagnosed glioblastoma be discontinued as it is unlikely to meet primary overall survival endpoint in patients with minimal residual disease
-
P.
Srivastava,
L.
Old
(1988)
Individually distinct transplantation antigens of chemically induced mouse tumors.
Immunology today, 9 3
-
(2016)
Data safety and monitoring board recommends celldex's phase 3 study of journals
-
Johannes
Berg,
Melissa
Vrohlings,
S.
Haller,
Aladin
Haimovici,
P.
Kulig,
A.
Śledzińska,
M.
Weller,
B.
Becher
(2013)
Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
The Journal of Experimental Medicine, 210
-
D.
Reardon,
J.
Sampson,
S.
Sahebjam,
M.
Lim,
J.
Baehring,
G.
Vlahović,
T.
Cloughesy,
L.
Strauss,
R.
Latek,
P.
Paliwal,
C.
Harbison,
A.
Voloschin,
A.
Omuro
(2016)
Safety and activity of nivolumab (nivo) monotherapy and nivo in combination with ipilimumab (ipi) in recurrent glioblastoma (GBM): Updated results from checkmate-143.
Journal of Clinical Oncology, 34
-
F.
Hodi,
D.
Oble,
J.
Drappatz,
E.
Velazquez,
N.
Ramaiya,
N.
Ramakrishna,
A.
Day,
A.
Kruse,
S.
Rae,
A.
Hoos,
M.
Mihm
(2008)
CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
Nature Clinical Practice Oncology, 5
-
J.
Leonard,
M.
Sherman,
G.
Fisher,
L.
Buchanan,
G.
Larsen,
M.
Atkins,
J.
Sosman,
J.
Dutcher,
N.
Vogelzang,
J.
Ryan
(1997)
Effects of Single-Dose Interleukin-12 Exposure on Interleukin-12–Associated Toxicity and Interferon-γ Production
Blood, 90
-
T.
Carter,
H.
Shaw,
Denise
Cohn-Brown,
K.
Chester,
P.
Mulholland,
P.
Mulholland
(2016)
Ipilimumab and Bevacizumab in Glioblastoma.
Clinical oncology (Royal College of Radiologists (Great Britain)), 28 10
-
O.
Bloch,
C.
Crane,
Yelena
Fuks,
R.
Kaur,
M.
Aghi,
M.
Berger,
N.
Butowski,
Susan
Chang,
Jennifer
Clarke,
M.
McDermott,
M.
Prados,
A.
Sloan,
J.
Bruce,
A.
Parsa
(2014)
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.
Neuro-oncology, 16 2
-
L.
Johnson,
J.
Scholler,
T.
Ohkuri,
A.
Kosaka,
Prachi
Patel,
S.
McGettigan,
A.
Nace,
T.
Dentchev,
Pramod
Thekkat,
A.
Loew,
A.
Boesteanu,
Alexandria
Cogdill,
Taylor J.
Chen,
J.
Fraietta,
Christopher
Kloss,
A.
Posey,
B.
Engels,
Reshma
Singh,
Tucker
Ezell,
N.
Idamakanti,
Melissa
Ramones,
Na
Li,
Li
Zhou,
G.
Plesa,
J.
Seykora,
H.
Okada,
C.
June,
J.
Brogdon,
M.
Maus
(2015)
Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma
Science Translational Medicine, 7
-
David
Barba,
Stephen
Saris,
Carol
Holder,
S.
Rosenberg,
E.
Oldfield
(1989)
Intratumoral LAK cell and interleukin-2 therapy of human gliomas.
Journal of neurosurgery, 70 2
-
A.
Marshall,
A.
Dayan
(1964)
AN IMMUNE REACTION IN MAN AGAINST SEMINOMAS, DYSGERMINOMAS, PINEALOMAS, AND THE MEDIASTINAL TUMOURS OF SIMILAR HISTOLOGICAL APPEARANCE?
Lancet, 2 7369
-
Structural and functional features of central nervous system lymphatic vessels
-
Todd
Hollon,
R.
Price,
C.
Kwon,
E.
Chiocca
(2013)
Mutations in glioblastoma oncosuppressive pathways pave the way for oncomodulatory activity of cytomegalovirus
Oncoimmunology, 2
-
R.
Verhaak,
K.
Hoadley,
E.
Purdom,
V.
Wang,
Y.
Qi,
M.
Wilkerson,
C.
Miller,
L.
Ding,
Todd
Golub,
J.
Mesirov,
G.
Alexe,
M.
Lawrence,
Michael
O’Kelly,
P.
Tamayo,
B.
Weir,
S.
Gabriel,
W.
Winckler,
Supriya
Gupta,
L.
Jakkula,
H.
Feiler,
J.
Hodgson,
C.
James,
J.
Sarkaria,
C.
Brennan,
A.
Kahn,
P.
Spellman,
R.
Wilson,
T.
Speed,
J.
Gray,
M.
Meyerson,
G.
Getz,
C.
Perou,
D.
Hayes
(2010)
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Cancer cell, 17 1
-
D.
Mitchell,
W.
Xie,
R.
Schmittling,
Chris
Learn,
A.
Friedman,
R.
McLendon,
J.
Sampson
(2008)
Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma.
Neuro-oncology, 10 1
-
Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143. 2015 ASCO Annual Meeting
-
Adam
Wu,
Jun
Wei,
L.
Kong,
Yongtao
Wang,
W.
Priebe,
W.
Qiao,
R.
Sawaya,
A.
Heimberger
(2010)
Glioma cancer stem cells induce immunosuppressive macrophages/microglia.
Neuro-oncology, 12 11
-
I.
Beswick,
G.
Qvist
(1963)
Spontaneous Regression of Cancer
British Medical Journal, 2
-
G.
Lammering,
K.
Valerie,
P.
Lin,
T.
Hewit,
R.
Schmidt‐Ullrich
(2004)
Radiation-induced activation of a common variant of EGFR confers enhanced radioresistance.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 72 3
-
A.
Heimberger,
R.
Hlatky,
D.
Suki,
David
Yang,
J.
Weinberg,
M.
Gilbert,
R.
Sawaya,
K.
Aldape
(2005)
Prognostic Effect of Epidermal Growth Factor Receptor and EGFRvIII in Glioblastoma Multiforme Patients
Clinical Cancer Research, 11
-
Leonel
Ampie,
W.
Choy,
J.
Lamano,
Shayan
Fakurnejad,
O.
Bloch,
A.
Parsa
(2015)
Heat shock protein vaccines against glioblastoma: from bench to bedside
Journal of Neuro-Oncology, 123
-
M.
Maleissye,
G.
Nicolas,
P.
Saiag
(2016)
Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy.
The New England journal of medicine, 375 3
-
R.
Sobol,
H.
Fakhrai,
D.
Shawler,
Ruth
Gjerset,
Oliver
Dorigo,
C.
Carson,
T.
Khaleghi,
James
Koziol,
Shiftan
Ta,
Ivor
Royston
(1995)
Interleukin-2 gene therapy in a patient with glioblastoma.
Gene therapy, 2 2
-
C.
Crane,
S.
Han,
Brian
Ahn,
Jessica
Oehlke,
V.
Kivett,
A.
Fedoroff,
N.
Butowski,
Susan
Chang,
J.
Clarke,
M.
Berger,
M.
McDermott,
M.
Prados,
A.
Parsa
(2012)
Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
Clinical Cancer Research, 19
-
C.
Yee,
John
Thompson,
John
Thompson,
D.
Byrd,
D.
Byrd,
S.
Riddell,
S.
Riddell,
P.
Roche,
E.
Celis,
P.
Greenberg,
P.
Greenberg
(2002)
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells
Proceedings of the National Academy of Sciences of the United States of America, 99
-
W.
Samlowski,
K.
Park,
R.
Galinsky,
J.
Ward,
G.
Schumann
(1993)
Intrathecal administration of interleukin-2 for meningeal carcinomatosis due to malignant melanoma: sequential evaluation of intracranial pressure, cerebrospinal fluid cytology, and cytokine induction.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy, 13 1
-
[Adoptive immunotherapy in patients with medulloblastoma by LAK cells] Japanese translation
-
J.
Sampson,
A.
Heimberger,
G.
Archer,
K.
Aldape,
A.
Friedman,
H.
Friedman,
M.
Gilbert,
J.
Herndon,
R.
McLendon,
D.
Mitchell,
D.
Reardon,
R.
Sawaya,
R.
Schmittling,
W.
Shi,
J.
Vredenburgh,
D.
Bigner
(2010)
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 31
-
K.
Kahlon,
Christine
Brown,
L.
Cooper,
A.
Raubitschek,
S.
Forman,
M.
Jensen
(2004)
Specific Recognition and Killing of Glioblastoma Multiforme by Interleukin 13-Zetakine Redirected Cytolytic T Cells
Cancer Research, 64
-
H.
Miao,
Bryan
Choi,
Carter
Suryadevara,
L.
Sanchez-Perez,
Shicheng
Yang,
G.
Leon,
E.
Sayour,
R.
McLendon,
J.
Herndon,
P.
Healy,
G.
Archer,
D.
Bigner,
L.
Johnson,
J.
Sampson
(2014)
EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma
PLoS ONE, 9
-
Shuiping
Jiang
(2008)
Regulatory T cells and clinical application
-
J.
Sampson,
K.
Aldape,
G.
Archer,
A.
Coan,
A.
Desjardins,
A.
Friedman,
H.
Friedman,
M.
Gilbert,
J.
Herndon,
R.
McLendon,
D.
Mitchell,
D.
Reardon,
R.
Sawaya,
R.
Schmittling,
W.
Shi,
J.
Vredenburgh,
D.
Bigner,
A.
Heimberger
(2011)
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.
Neuro-oncology, 13 3
-
W.
Brooks,
M.
Netsky,
D.
Normansell,
D.
Horwitz
(1972)
DEPRESSED CELL-MEDIATED IMMUNITY IN PATIENTS WITH PRIMARY INTRACRANIAL TUMORS
The Journal of Experimental Medicine, 136
-
H.
Kono,
K.
Rock
(2008)
How dying cells alert the immune system to danger
Nature Reviews Immunology, 8
-
G.
Lammering,
T.
Hewit,
M.
Holmes,
K.
Valerie,
W.
Hawkins,
P.
Lin,
R.
Mikkelsen,
R.
Schmidt‐Ullrich
(2004)
Inhibition of the Type III Epidermal Growth Factor Receptor Variant Mutant Receptor by Dominant-Negative EGFR-CD533 Enhances Malignant Glioma Cell Radiosensitivity
Clinical Cancer Research, 10
-
W.
Brooks,
T.
Roszman,
M.
Mahaley,
R.
Woosley
(1977)
Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours.
Clinical and experimental immunology, 29 1
-
H.
Caruso,
H.
Torikai,
Ling
Zhang,
S.
Maiti,
Jianliang
Dai,
K.
Do,
Harjeet
Singh,
H.
Huls,
Dean
Lee,
R.
Champlin,
A.
Heimberger,
L.
Cooper
(2016)
Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor
Journal of Immunotherapy, 39
-
C.
Maurice,
R.
Schneider,
T.
Kiehl,
P.
Bavi,
M.
Roehrl,
W.
Mason,
D.
Hogg
(2015)
Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma
Cancer Immunology Research, 3
-
H.
Okada,
P.
Kalinski,
R.
Ueda,
A.
Hoji,
G.
Kohanbash,
T.
Donegan,
A.
Mintz,
J.
Engh,
D.
Bartlett,
C.
Brown,
H.
Zeh,
M.
Holtzman,
T.
Reinhart,
T.
Whiteside,
L.
Butterfield,
R.
Hamilton,
D.
Potter,
I.
Pollack,
A.
Salazar,
F.
Lieberman
(2011)
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 3
-
D.
Schadendorf,
F.
Hodi,
C.
Robert,
J.
Weber,
K.
Margolin,
O.
Hamid,
D.
Patt,
Tai-Tsang
Chen,
D.
Berman,
J.
Wolchok
(2015)
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 17
-
R.
Dillman,
C.
Duma,
R.
Ellis,
A.
Cornforth,
P.
Schiltz,
S.
Sharp,
Madeline
DePriest
(2009)
Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma
Journal of Immunotherapy, 32
-
M.
Teo,
Sean
Martin,
K.
Owusu-Agyemang,
S.
Nowicki,
B.
Clark,
M.
Mackinnon,
Willie
Stewart,
J.
Paul,
J.
George
(2014)
A survival analysis of GBM patients in the West of Scotland pre- and post-introduction of the Stupp regime
British Journal of Neurosurgery, 28
-
J.
Leonard,
M.
Sherman,
G.
Fisher,
L.
Buchanan,
G.
Larsen,
M.
Atkins,
J.
Sosman,
J.
Dutcher,
N.
Vogelzang,
J.
Ryan
(1997)
Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.
Blood, 90 7
-
J.
Knisely,
James
Yu,
Jaclyn
Flanigan,
M.
Sznol,
H.
Kluger,
V.
Chiang
(2012)
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival.
Journal of neurosurgery, 117 2
-
Everson
Tc
(1967)
Spontaneous regression of cancer.
Progress in clinical cancer, 3
-
A.
Wu,
Jing
Xiao,
L.
Anker,
W.
Hall,
D.
Gregerson,
W.
Cavenee,
W.
Chen,
W.
Low
(2005)
Identification of EGFRvIII-derived CTL Epitopes Restricted by HLA A0201 for Dendritic Cell Based Immunotherapy of Gliomas
Journal of Neuro-Oncology, 76
-
P.
Agarwalla,
Z.
Barnard,
P.
Fecci,
G.
Dranoff,
W.
Curry
(2012)
Sequential Immunotherapy by Vaccination With GM-CSF–expressing Glioma Cells and CTLA-4 Blockade Effectively Treats Established Murine Intracranial Tumors
Journal of Immunotherapy, 35
-
R.
Hayes,
M.
Koslow,
E.
Hiesiger,
K.
Hymes,
E.
Moore,
D.
Pierz,
H.
Hochster,
Doris
Chen,
G.
Budzilovich,
J.
Ransohoff
(1995)
Improved long term survival after intracavitary interleukin‐2 and lymphokine‐activated killer cells for adults with recurrent malignant glioma
Cancer, 76
-
P.
Medawar
(1948)
Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye.
British journal of experimental pathology, 29 1
-
F.
Hodi,
S.
O'Day,
D.
McDermott,
R.
Weber,
J.
Sosman,
J.
Haanen,
R.
Gonzalez,
C.
Robert,
D.
Schadendorf,
Jessica
Hassel,
W.
Akerley,
A.
Eertwegh,
J.
Lutzky,
P.
Lorigan,
J.
Vaubel,
G.
Linette,
D.
Hogg,
C.
Ottensmeier,
C.
Lebbé,
C.
Peschel,
I.
Quirt,
Joseph
Clark,
J.
Wolchok,
J.
Weber,
Jason
Tian,
M.
Yellin,
G.
Nichol,
A.
Hoos,
W.
Urba
(2010)
Improved survival with ipilimumab in patients with metastatic melanoma.
The New England journal of medicine, 363 8
-
M.
Pule,
B.
Savoldo,
G.
Myers,
C.
Rossig,
H.
Russell,
G.
Dotti,
M.
Huls,
E.
Liu,
A.
Gee,
Z.
Mei,
E.
Yvon,
H.
Weiss,
Hao
Liu,
C.
Rooney,
H.
Heslop,
M.
Brenner
(2008)
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Nature Medicine, 14
-
J.
Qian,
James
Yu,
H.
Kluger,
V.
Chiang
(2016)
Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery
Cancer, 122
-
A.
Berghoff,
B.
Kiesel,
G.
Widhalm,
Orsolya
Rajky,
G.
Ricken,
A.
Wöhrer,
K.
Dieckmann,
M.
Filipits,
A.
Brandstetter,
M.
Weller,
Sebastian
Kurscheid,
M.
Hegi,
C.
Zielinski,
C.
Marosi,
J.
Hainfellner,
M.
Preusser,
W.
Wick
(2015)
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.
Neuro-oncology, 17 8
-
R.
Baluna,
E.
Vitetta
(1997)
Vascular leak syndrome: a side effect of immunotherapy.
Immunopharmacology, 37 2-3
-
R.
Conry,
J.
Sullivan,
L.
Nabors
(2015)
Ipilimumab-Induced Encephalopathy with a Reversible Splenial Lesion
Cancer Immunology Research, 3
-
R.
Prins,
T.
Cloughesy,
L.
Liau
(2008)
Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate.
The New England journal of medicine, 359 5
-
Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor
-
C.
Cobbs
(2013)
Cytomegalovirus and brain tumor: epidemiology, biology and therapeutic aspects
Current Opinion in Oncology, 25
-
A.
Ridley,
J.
Cavanagh
(1969)
The cellular reactions to heterologous, homologous and autologous skin implanted into brain
The Journal of Pathology, 99
-
C.
Robert,
J.
Schachter,
G.
Long,
A.
Arance,
J.
Grob,
L.
Mortier,
A.
Daud,
M.
Carlino,
C.
McNeil,
M.
Lotem,
J.
Larkin,
P.
Lorigan,
B.
Neyns,
C.
Blank,
O.
Hamid,
C.
Mateus,
R.
Shapira-Frommer,
M.
Kosh,
Honghong
Zhou,
N.
Ibrahim,
S.
Ebbinghaus,
A.
Ribas
(2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma.
The New England journal of medicine, 372 26
-
P.
Voisin,
V.
Bouchaud,
M.
Merle,
P.
Diolez,
L.
Duffy,
Kristian
Flint,
J.
Franconi,
A.
Bouzier-Sore
(2010)
Microglia in Close Vicinity of Glioma Cells: Correlation Between Phenotype and Metabolic Alterations
Frontiers in Neuroenergetics, 2
-
Bei
Liu,
Anna
DeFilippo,
Zihai
Li
(2002)
Overcoming immune tolerance to cancer by heat shock protein vaccines.
Molecular cancer therapeutics, 1 12
-
S.
Salam,
T.
Lavin,
A.
Turan
(2016)
Limbic encephalitis following immunotherapy against metastatic malignant melanoma
BMJ Case Reports, 2016
-
Wei
Li,
M.
Graeber
(2012)
The molecular profile of microglia under the influence of glioma.
Neuro-oncology, 14 8
-
C.
Rothermundt,
Claudia
Hader,
Silke
Gillessen
(2016)
Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer.
Annals of oncology : official journal of the European Society for Medical Oncology, 27 3
-
A.
Salmaggi,
A.
Dufour,
A.
Silvani,
E.
Ciusani,
A.
Nespolo,
A.
Boiardi
(1994)
Immunological fluctuations during intrathecal immunotherapy in three patients affected by CNS tumours disseminating via CSF.
The International journal of neuroscience, 77 1-2
-
G.
Dunn,
H.
Okada
(2015)
Principles of immunology and its nuances in the central nervous system.
Neuro-oncology, 17 Suppl 7
-
O.
Kanai,
K.
Fujita,
M.
Okamura,
K.
Nakatani,
T.
Mio
(2016)
Severe exacerbation or manifestation of primary disease related to nivolumab in non-small-cell lung cancer patients with poor performance status or brain metastases.
Annals of oncology : official journal of the European Society for Medical Oncology, 27 7
-
H.
Okada,
L.
Butterfield,
R.
Hamilton,
A.
Hoji,
M.
Sakaki,
Brian
Ahn,
G.
Kohanbash,
J.
Drappatz,
J.
Engh,
N.
Amankulor,
M.
Lively,
M.
Chan,
A.
Salazar,
E.
Shaw,
D.
Potter,
F.
Lieberman
(2014)
Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
Clinical Cancer Research, 21
-
V.
Schijns,
C.
Pretto,
L.
Devillers,
Denis
Pierre,
F.
Hofman,
Thomas
Chen,
Pascal
Mespouille,
P.
Hantos,
P.
Glorieux,
D.
Bota,
A.
Stathopoulos
(2015)
First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity
Vaccine, 33
-
R.
Darnell,
J.
Posner
(2006)
Paraneoplastic syndromes affecting the nervous system.
Seminars in oncology, 33 3
-
J.
Sampson,
G.
Vlahović,
S.
Sahebjam,
A.
Omuro,
J.
Baehring,
D.
Hafler,
A.
Voloschin,
P.
Paliwal,
J.
Grosso,
V.
Coric,
T.
Cloughesy,
M.
Lim,
D.
Reardon
(2015)
Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143.
Journal of Clinical Oncology, 33
-
C.
Lamers,
S.
Sleijfer,
A.
Vulto,
W.
Kruit,
M.
Kliffen,
R.
Debets,
J.
Gratama,
G.
Stoter,
E.
Oosterwijk
(2006)
Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 13
-
J.
Weber,
John
Thompson,
O.
Hamid,
D.
Minor,
A.
Amin,
I.
Ron,
R.
Ridolfi,
H.
Assi,
A.
Maraveyas,
D.
Berman,
J.
Siegel,
S.
O'Day
(2009)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma
Clinical Cancer Research, 15
-
A.
Pietro,
G.
Tosti,
P.
Ferrucci,
A.
Testori
(2008)
Oncophage: step to the future for vaccine therapy in melanoma.
Expert opinion on biological therapy, 8 12
-
M.
Cunningham,
S.
Essapen,
H.
Thomas,
Margaret
Green,
D.
Lovell,
C.
Topham,
Christopher
Marks,
H.
Modjtahedi
(2005)
Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer.
International journal of oncology, 27 2
-
C.
Meyers,
W.
Yung
(1993)
Delayed neurotoxicity of intraventricular interleukin-2: A case report
Journal of Neuro-Oncology, 15